Technologies combining MRI, robotics, and artificial intelligence are changing the way prostate cancer is diagnosed and ...

New blood test could show if prostate cancer treatment is failing - The discovery could lead to personalised treatments for the disease ...

Tempus AI (NasdaqGS:TEM) has launched the ArteraAI Prostate Test, its first externally developed AI-powered digital pathology test for metastatic hormone-sensitive prostate cancer. The test is ...

Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, and University College London (UCL) today announced that data published online in ...

Routine prostate cancer screening has been rejected by the UK's independent screening committee despite significant pressure ...

The Government’s plans for prostate cancer screening do not go far enough, experts have warned. James Murray, the new Health ...

Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...

Sponsor activations are common in auto racing and all modern sports. This one, however, could literally save lives.

Experts are trying to find the best way to screen for prostate cancer, since blood tests alone are not accurate enough for ...